Related Experiment Video
Updated: Jun 30, 2026

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
Endoscopic findings and Helicobacter pylori in children on long-term hemodialysis
Fakhrossadat Mortazavi1, Mandana Rafeey
1Department of Pediatric Nephrology, Faculty of Medicine, Liver and Gastroenterology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Insights
Gastrointestinal issues and Helicobacter pylori infection are common in children with End Stage Renal Disease (ESRD) on hemodialysis. Pre-transplant upper GI evaluation is crucial for these pediatric patients.
Area of Science:
- Pediatric Nephrology
- Gastroenterology
- Infectious Diseases
Background:
- End Stage Renal Disease (ESRD) impacts multiple organ systems, including the gastrointestinal (GI) tract.
- Children undergoing maintenance hemodialysis face unique health challenges.
- Limited data exists on GI pathology and Helicobacter pylori infection in pediatric ESRD patients.
Purpose of the Study:
- To determine the prevalence of GI symptoms.
- To assess endoscopic abnormalities and histologic gastritis.
- To evaluate Helicobacter pylori infection rates in children with ESRD before renal transplantation.
Main Methods:
- Upper endoscopy and gastric biopsies were performed on 31 pediatric ESRD patients.
- Helicobacter pylori status was assessed using urease testing and histology.
- Data on patient demographics, dialysis duration, and clinical symptoms were collected.
Main Results:
- 54.8% of patients experienced GI symptoms, and 64.5% had endoscopic abnormalities.
- Common findings included antral erythema, esophagitis, and diffuse gastritis.
- H. pylori infection was present in 64.5% of patients, with no correlation to age, sex, or symptoms.
Conclusions:
- A high prevalence of endoscopic abnormalities and H. pylori infection exists in pediatric ESRD patients.
- Endoscopic findings were more frequent in symptomatic patients.
- Upper GI evaluation is recommended for ESRD children prior to renal transplantation.
Abstract:
The aim of this study is to evaluate the prevalence of GI symptoms, endoscopic abnormalities, histologic gastritis and Helicobacter pylori infection in children with End Stage Renal Disease (ESRD) undergoing maintenance hemodialysis. Upper endoscopy and gastric biopsy were performed in 31 consecutive ESRD children from 2002-2007, before renal transplantation. H. pylori status was determined by urease test and histology. The mean age of patients was 11 +/- 3.3 years (4-16 year). The mean duration of dialysis was 12.4 +/- 11 months (1.5-54 months). Seventeen patients (54.8%) were symptomatic. Twenty patients (64.5%) had endoscopic abnormalities. Antral erythema, esophagitis, antral nodularity and diffuse gastritis were common endoscopic findings. Endoscopic abnormalities were more common in symptomatic patients than asymptomatic patients (p < 0.05). Twenty patients (64.5%) were H. pylori positive. There was no statistical correlation between age, sex, serum creatinine level, presence of any symptoms and endoscopic abnormalities with H. pylori positivity. The mean duration of dialysis in H. pylori negative patients was significantly longer in comparison with H. pylori positive patients. High prevalence of eodoscopic abnormalities and H. pylori infection in both symptomatic and asymptomatic patients emphasize the necessity of upper GI evaluation in ESRD children before renal transplantation.
Related Concept Videos
Peptic Ulcer
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Gastritis II: Pathophysiology
Peptic Ulcer Disease III: Clinical Manifestations and Complications
Peptic Ulcer Disease II: Pathophysiology
